Sam Chun Dang Pharm. Co. Ltd (000250) — Cash Flow Quality Index
Sam Chun Dang Pharm. Co. Ltd (000250) has a Cash Flow Quality Index of 2.86x as of June 2026. Operating cash flow of ₩12.04 Billion exceeds net income of ₩4.21 Billion, indicating high earnings quality where cash backs reported profits. Explore Sam Chun Dang Pharm. Co. Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sam Chun Dang Pharm. Co. Ltd Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Sam Chun Dang Pharm. Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 000250 cash flow metrics.
Annual Cash Flow Quality Index for Sam Chun Dang Pharm. Co. Ltd (2012–2025)
Year-by-year earnings quality comparison for Sam Chun Dang Pharm. Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.86x | ₩9.79 Billion | ₩5.26 Billion | ▼ -18.2% |
| 2022 | 2.27x | ₩13.28 Billion | ₩5.84 Billion | ▲ +55.3% |
| 2019 | 1.46x | ₩30.60 Billion | ₩20.89 Billion | ▼ -20.7% |
| 2018 | 1.85x | ₩25.03 Billion | ₩13.55 Billion | ▼ -11.4% |
| 2017 | 2.08x | ₩26.09 Billion | ₩12.51 Billion | ▲ +83.2% |
| 2016 | 1.14x | ₩17.76 Billion | ₩15.61 Billion | ▲ +17.3% |
| 2015 | 0.97x | ₩17.34 Billion | ₩17.87 Billion | ▼ -41.2% |
| 2014 | 1.65x | ₩19.55 Billion | ₩11.85 Billion | ▼ -9.7% |
| 2013 | 1.83x | ₩15.94 Billion | ₩8.72 Billion | ▲ +52.9% |
| 2012 | 1.20x | ₩1.60 Billion | ₩1.34 Billion | — |